Breakthrough therapies.

Latest bill text (Comm Sub) [PDF]


Breakthrough therapies. Establishes the breakthrough therapies research fund. Provides that a drug, biological product, or medical device that has been designated as a breakthrough therapy under federal law may be made available to a qualified patient and offered by a physician as a part of the patient's medical treatment. Specifies that a civil or criminal cause of action is not created against a manufacturer or health care provider for any harm to a qualified patient resulting from use of an investigational drug, biological product, or device.


Authored by Representative Moed

Fiscal Outlook

Title Description Date View
Fiscal NoteFiscal Note #1: Introduced2024-01-08 Click To View


Date Chamber Action
2024-01-09HouseFirst reading: referred to Committee on Public Health
2024-01-09HouseAuthored by Representative Moed